19036-73-8 ((S)-1-(3-三氟甲基苯基)-2-氨基丙烷,(2S)-1-3-(trifluoromethyl)phenylpropan-2-amine)

(S)-1-(3-三氟甲基苯基)-2-氨基丙烷;

Benzeneethanamine, a-methyl-3-(trifluoromethyl)-, (aS)-;(S)-1-(3-TRIFLUOROMETHYLPHENYL)-2-AMINOPROPANE;(+)-1-(3-aminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile;(+)-didesmethylcitalopram;(2S)-2-[4-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)phenyl]propanoic acid;(S)-didesmethylcitalopram;(S)-N-didemethyl-citalopram;(S)-norfenfluramine;Dexibuprofen Lysine;d-norfenfluramine;nor-(+)-fenfluramine;S-(+)-didesmethyl citalopram;S(+)-ibuprofen lysinate monohydra;S-(+)-norfenfluramine;UNII-JM43W5556T;Einecs 242-769-7;S-Norfenfluramine;Nordexfenfluramine;Dexnorfenfluramine;(S)-1-(3-TRIFLUOROMETHYLPHENYL)-2-PROPANAMINE;(S)-1-(3-(trifluoromethyl)phenyl)propan-2-amine;(S)-α-Methyl-3-(trifluoromethyl)benzeneethanamine;(S)-alpha-methyl-m-(trifluoromethyl)phenethylamine;[S,(+)]-α-Methyl-m-(trifluoromethyl)phenethylamine;MFCD00671675;Norfenfluramine (-);(S)-1-(3-Trifluoromethyl-phenyl)-2-aminopropane;BENZENEETHANAMINE, .ALPHA.-METHYL-3-(TRIFLUOROMETHYL)-, (S)-;Norfenfluramine, (+)-;BENZENEETHANAMINE, .ALPHA.-METHYL-3-(TRIFLUOROMETHYL)-, (.ALPHA.S)-;CS-0197703;LS-193348;PHENETHYLAMINE, .ALPHA.-METHYL-M-(TRIFLUOROMETHYL)-, (S)-;Norfenfluramine, (S)-;(+)-norfenfluramine;CHEBI:125533;AKOS027378233;CHEMBL253811;BDBM85530;SCHEMBL4668266;(2S)-1-[3-(trifluoromethyl)phenyl]propan-2-amine;CLX07A6ZIY;PDSP1_001424;NCGC00186044-01;Nor-dexfenfluramine;PDSP1_000698;PDSP2_001406;Q27088005;PDSP2_001408;SDCCGSBI-0633814.P001;EN300-1932182;UNII-CLX07A6ZIY;Norfenfluramine (+);D0U7BH;BRD-K31460632-001-01-8;GTPL216;MLBHFBKZUPLWBD-ZETCQYMHSA-N;Nor-d-fenfluramine;PDSP2_000688;AS-69910;19036-73-8;Benzeneethanamine, alpha-methyl-3-(trifluoromethyl)-, (alphaS)-;(2S)-1-3-(trifluoromethyl)phenylpropan-2-amine;NS00085682;DA-48583;

MFCD00671675

MLBHFBKZUPLWBD-ZETCQYMHSA-N

1S/C10H12F3N/c1-7(14)5-8-3-2-4-9(6-8)10(11,12)13/h2-4,6-7H,5,14H2,1H3/t7-/m0/s1

FC(C1=CC=CC(=C1)C[C@H](C)N)(F)F